Endometrial cancer and hormone-replacement therapy in the Million Women Study

This publication has 21 references indexed in Scilit:

• Tibolone and Endometrial Cancer
  Drug Safety, 2005
• Hormone replacement therapy and incidence of hormone‐dependent cancers in the Norwegian Women and Cancer study
  International Journal of Cancer, 2004
• Carcinoma of the endometrium in patients treated with tibolone
  Gynecologic Oncology, 2004
• Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women
  International Journal of Cancer, 2003
• Breast cancer and hormone-replacement therapy in the Million Women Study
  The Lancet, 2003
• Patterns of use of hormone replacement therapy in one million women in Britain, 1996–2000
  BJOG: An International Journal of Obstetrics and Gynaecology, 2002
• Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses
  Journal of Epidemiology and Biostatistics, 2001
• Hormone replacement therapy and endometrial cancer risk: A meta-analysis
  Obstetrics & Gynecology, 1995
• Estrogens, Progesterone, and Endometrial Cancer
  Epidemiology, 1993
• Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.
  BMJ, 1989